A synthetic peptide for use as a blocking control in assays to test for specificity of RNF40 antibody, Alternative Names: RNF40 control peptide, RNF40 antibody Blocking Peptide, Anti-RNF40 Blocking Peptide, Ring Finger Protein 40 Blocking Peptide, BRE1B Blocking Peptide, DKFZp686K191 Blocking Peptide, KIAA0661 Blocking Peptide, MGC13051 Blocking Peptide, RBP95 Blocking Peptide, STARING Blocking Peptide, RNF40, RNF-40, RNF 40, RNF-40 Blocking Peptide, RNF 40 Blocking Peptide
RNF40
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
RNF40
(Ring Finger Protein 40, E3 Ubiquitin Protein Ligase (RNF40))
Hintergrund
RNF40 contains a RING finger, a motif known to be involved in protein-protein and protein-DNA interactions. This protein was reported to interact with the tumor suppressor protein RB1. Studies of the rat counterpart suggested that this protein may function as an E3 ubiquitin-protein ligase, and facilitate the ubiquitination and degradation of syntaxin 1, which is an essential component of the neurotransmitter release machinery.